Cancer News and Research

Latest Cancer News and Research

CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer

Eisai Inc. announced today that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Halaven (eribulin mesylate) Injection.

4 Jan 2012

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

Can-Fite BioPharma Ltd, a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange announced today the successful results of the Phase 1/2 study of its drug candidate CF102 in the treatment of hepatocellular carcinoma.

4 Jan 2012

iCAD enters $15M debt facility agreement with Deerfield Management

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it has entered into a five year, $15 million debt facility agreement with Deerfield Management Company LP, a leading healthcare investment fund.

3 Jan 2012

TrovaGene acquires license to mutations of SF3B1 splicing factor in CLL

TrovaGene, Inc., a developer of trans-renal molecular diagnostics, today announced that it has obtained an exclusive worldwide license to mutations of the SF3B1 splicing factor, which have been shown to be associated with disease progression and chemotherapy response in patients suffering from chronic lymphocytic leukemia.

3 Jan 2012

Regeneron, Genentech enter non-exclusive license and partial settlement agreement for EYLEA

Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.

3 Jan 2012

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

AVEO Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that tivozanib demonstrated superiority over sorafenib in the primary endpoint of progression-free survival (PFS) in TIVO-1, a global, randomized Phase 3 clinical trial evaluating the efficacy and safety of investigational drug tivozanib compared to sorafenib in 517 patients with advanced renal cell carcinoma.

3 Jan 2012

Lundbeck invests in Ossianix to focus on biotherapeutics for CNS disorders

Ossianix, Inc. today announced a strategic investment by H. Lundbeck A/S in the form of a Convertible Promissory Note. The proceeds from Lundbeck's investment is expected to allow Ossianix to generate biopharmaceuticals for the treatment of nervous system disorders by utilizing Ossianix's proprietary single domain antibody platform modeled on the shark vNAR structure.

3 Jan 2012

FDA sets Feb. 9 for ODAC meeting to review CTI's resubmitted pixantrone NDA

Cell Therapeutics, Inc. (CTI) announced today that on February 9, 2012 the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) will review CTI's resubmitted New Drug Application (NDA) for pixantrone for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL) in patients who failed two or more lines of prior therapy.

3 Jan 2012

Scientists show how HCV virus hijacks miR-122 in liver cells

Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment.

2 Jan 2012

Smokers prefer cold turkey - launch of study into quitting smoking including popular cold turkey method

Cold turkey is the preferred method for giving up smoking according to public health researchers at the University of Sydney. With more than two-thirds of smokers giving up permanently this way the research team wants to know why.

2 Jan 2012

More than half smokers unaware of health risks: NHS Survey

The figures come from NHS Smokefree research that showed that 53% of smokers underestimate the number of annual deaths from smoking-related diseases by at least 70,000. The actual number of such deaths is more than 80,000.

2 Jan 2012

Issue of NCDs in post-conflict countries must be addressed, say experts

Countries recovering from war are at risk of being left to their own devices in tackling non communicable diseases, leaving an "open door" for exploitation by alcohol, tobacco and food companies, health experts warn.

2 Jan 2012

2012 & health care: Medicare faces big changes, new state laws include abortion issues

News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.

2 Jan 2012

Hospitals may be treating patients as part of “production line” with early discharges requiring readmissions: Report

After figures revealed that hundreds of thousands of people every year are being sent home before they are well enough, hospitals have been accused by ministers of treating patients “like parts on a production line.”

1 Jan 2012

Four or more coffees reduce risk of womb cancer

According to a new study drinking four or more cups of coffee a day may reduce risk of developing endometrial cancer or womb cancer by almost 25 per cent.

1 Jan 2012

Britain mulling on cigarette plain packaging to discourage smoking

Britain wishes to follow Australia’s footsteps in banning all eye-catching designs and branding from cigarette packs to stop young people being lured into smoking. Australia meanwhile is poised to become the first nation to introduce so-called “plain” packaging on tobacco products by the end of 2012. The packs will show graphic health warnings about smoking but banish attractive colors and logos. The proposed law was cleared by parliament in November and is being closely watched by governments considering similar moves in Europe, Canada and New Zealand.

1 Jan 2012

Similar sounding drug names should come with warnings

There have been mix ups and medication errors with similar sounding names of drugs - eye drops called Durezol and salicylic acid-containing wart remedy Duresal for example.

1 Jan 2012

ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program

ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS Access program.

31 Dec 2011

CHEST Foundation awards $100,000 for development of blood test for lung cancer

Lung cancer takes a heavy toll, contributing to more cancer deaths in the United States each year than breast, prostate and colon cancers combined. Contributing to this poor prognosis is the fact that lung cancer often goes undetected until the disease has reached an advanced and more difficult-to-treat stage.

31 Dec 2011

Lucid closes underwritten public offering

Lucid, Inc. today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock.

31 Dec 2011

Cancer News and Research

Latest Cancer News and Research

CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer

Positive results from Can-Fite BioPharma's CF102 Phase 1/2 study on HCC

iCAD enters $15M debt facility agreement with Deerfield Management

TrovaGene acquires license to mutations of SF3B1 splicing factor in CLL

Regeneron, Genentech enter non-exclusive license and partial settlement agreement for EYLEA

Astellas, AVEO announce results of tivozanib and sorafenib comparison trial on RCC

Lundbeck invests in Ossianix to focus on biotherapeutics for CNS disorders

FDA sets Feb. 9 for ODAC meeting to review CTI's resubmitted pixantrone NDA

Scientists show how HCV virus hijacks miR-122 in liver cells

Smokers prefer cold turkey - launch of study into quitting smoking including popular cold turkey method

More than half smokers unaware of health risks: NHS Survey

Issue of NCDs in post-conflict countries must be addressed, say experts

2012 & health care: Medicare faces big changes, new state laws include abortion issues

Hospitals may be treating patients as part of “production line” with early discharges requiring readmissions: Report

Four or more coffees reduce risk of womb cancer

Britain mulling on cigarette plain packaging to discourage smoking

Similar sounding drug names should come with warnings

ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program

CHEST Foundation awards $100,000 for development of blood test for lung cancer

Lucid closes underwritten public offering

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in